These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11930881)

  • 1. [Therapy resistant hyperlipidemia].
    Saltevo J; Kunnamo I
    Duodecim; 1999; 115(13):1415,1419. PubMed ID: 11930881
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperlipidemia in diabetes mellitus. Pathogenesis, diagnosis and drug therapy--a review].
    Johansen K
    Ugeskr Laeger; 1990 Feb; 152(9):584-8. PubMed ID: 2408221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitizer affects lipids.
    Health News; 2005 Jan; 11(1):2. PubMed ID: 15726701
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-prandial hyperlipidemia and hypertriglyceridemia.
    Mohan LR; Mohan V
    J Assoc Physicians India; 2001 Jan; 49 Spec No():19-21. PubMed ID: 11235599
    [No Abstract]   [Full Text] [Related]  

  • 5. Dyslipidemia in type 2 diabetes.
    Krauss RM; Siri PW
    Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integrated drug therapy of the metabolic syndrome].
    Julius U; Hanefeld M
    Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266
    [No Abstract]   [Full Text] [Related]  

  • 7. Dyslipidaemia in diabetes--a GP guide.
    Barnett AH
    Practitioner; 2002 Feb; 246(1631):120-3. PubMed ID: 11852620
    [No Abstract]   [Full Text] [Related]  

  • 8. [Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus].
    Panchenko VM; Ershov AA; Isaev VA; ZImovchenko GS; Chernova GI
    Klin Med (Mosk); 2001; 79(6):47-9. PubMed ID: 11521381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic approach to managing hyperglycemia for the nonendocrinologist.
    Deeg MA
    Am J Cardiol; 2005 Aug; 96(4A):37E-40E. PubMed ID: 16098842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN; Tuomilehto J; Hamann A; Kallend D; Smith K
    Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of hyperglycemia and the prognosis of adult-onset diabetes mellitus].
    Niskanen L; Uusitupa M; Laakso M
    Duodecim; 1999; 115(10):1122-4. PubMed ID: 11877851
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting of the minds. Should pre-hypertension in type 2 diabetes be treated?
    Bihl G; Amod A; Ellis G; Moore R; Raal FJ; Gernholtz T; Schamroth C; Horak A
    Cardiovasc J Afr; 2010; 21(3 Suppl):S9-S13. PubMed ID: 20532426
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug therapy for hyperlipidemia.
    Franklin FA; Margolis S
    Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperlipidaemia associated to inaugurated diabetic ketoacidosis].
    Matoussi N; Aissa K; Fitouri Z; Cheour M; Ben Becher S
    Tunis Med; 2006 Oct; 84(10):658-9. PubMed ID: 17193862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of dyslipidemias and its benefits].
    Taskinen MR
    Duodecim; 1999; 115(10):1138-44. PubMed ID: 11877853
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of type 2 diabetes].
    Daubresse JC
    Rev Med Brux; 2004 Feb; 25(1):22-8. PubMed ID: 15053151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimal therapeutic strategy in type 2 diabetes mellitus].
    Scherbaum WA; Nitschmann S
    Internist (Berl); 2009 Feb; 50(2):244-8. PubMed ID: 19183919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.